Simonelli C - Search Results

1

Dose-finding trial of a combined regimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An Italian Oncology Group for Clinical Research (GOIRC) study.

Buti S, Lazzarelli S, Chiesa MD, Simonelli C, Re GL, Lheshi A, Simon S, Mattioli R, Caminiti C, Mazza G, Donini M, Passalacqua R; GOIRC (Italian Oncology Group for Clinical Research). Buti S, et al. Among authors: simonelli c. J Immunother. 2010 Sep;33(7):735-41. doi: 10.1097/CJI.0b013e3181eb8289. J Immunother. 2010. PMID: 20664353 Clinical Trial.

2

FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature.

Berretta M, Di Benedetto F, Bearz A, Simonelli C, Martellotta F, Del Ben C, Berretta S, Spina M, Tirelli U. Berretta M, et al. Among authors: simonelli c. Cancer Invest. 2008 Jul;26(6):610-4. doi: 10.1080/07357900701781747. Cancer Invest. 2008. PMID: 18584352 Review.

3

Bevacizumab plus irinotecan-, fluorouracil-, and leucovorin-based chemotherapy with concomitant HAART in an HIV-positive patient with metastatic colorectal cancer.

Berretta M, Lleshi A, Zanet E, Bearz A, Simonelli C, Fisichella R, Nasti G, Berretta S, Tirelli U. Berretta M, et al. Among authors: simonelli c. Onkologie. 2008 Jul;31(7):394-7. doi: 10.1159/000132360. Epub 2008 Jun 16. Onkologie. 2008. PMID: 18596388

4

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.

Bearz A, Garassino I, Cavina R, Favaretto A, Boccalon M, Talamini R, Berretta M, Spazzapan S, Simonelli C, Santoro A, Tirelli U. Bearz A, et al. Among authors: simonelli c. Lung Cancer. 2008 May;60(2):240-5. doi: 10.1016/j.lungcan.2007.10.008. Epub 2007 Nov 26. Lung Cancer. 2008. PMID: 18022729

5

Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma.

Simonelli C, Zanussi S, Cinelli R, Dal Maso L, Di Gennaro G, D'Andrea M, Nasti G, Spina M, Vaccher E, De Paoli P, Tirelli U. Simonelli C, et al. Clin Infect Dis. 2003 Sep 15;37(6):820-7. doi: 10.1086/377204. Epub 2003 Aug 28. Clin Infect Dis. 2003. PMID: 12955644

6

Virological efficacy in HIV-infected patients affected by non-Hodgkin lymphoma, treated with antiblastic chemotherapy and highly active antiretroviral therapy.

Simonelli C, Zanussi S, Cinelli R, Dal Maso L, Di Gennaro G, D'Andrea M, Nasti G, Spina M, Vaccher E, De Paoli P, Tirelli U. Simonelli C, et al. Scand J Infect Dis Suppl. 2003;106:49-53. doi: 10.1080/03008870310009678. Scand J Infect Dis Suppl. 2003. PMID: 15000584

7

Unusual presentation of metastatic hepatocellular carcinoma in an HIV/HCV coinfected patient: case report and review of the literature.

Berretta M, Zanet E, Di Benedetto F, Simonelli C, Bearz A, Morra A, Bonanno S, Berretta S, Tirelli U. Berretta M, et al. Among authors: simonelli c. Tumori. 2008 Jul-Aug;94(4):589-91. doi: 10.1177/030089160809400424. Tumori. 2008. PMID: 18822699 Review.

8

Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.

Vaccher E, Spina M, Talamini R, Zanetti M, di Gennaro G, Nasti G, Tavio M, Bernardi D, Simonelli C, Tirelli U. Vaccher E, et al. Among authors: simonelli c. Clin Infect Dis. 2003 Dec 1;37(11):1556-64. doi: 10.1086/379517. Epub 2003 Nov 6. Clin Infect Dis. 2003. PMID: 14614680

9

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.

Spina M, Jaeger U, Sparano JA, Talamini R, Simonelli C, Michieli M, Rossi G, Nigra E, Berretta M, Cattaneo C, Rieger AC, Vaccher E, Tirelli U. Spina M, et al. Among authors: simonelli c. Blood. 2005 Mar 1;105(5):1891-7. doi: 10.1182/blood-2004-08-3300. Epub 2004 Nov 18. Blood. 2005. PMID: 15550484 Free article. Clinical Trial.

10

Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy.

Simonelli C, Tedeschi R, Gloghini A, Bortolin MT, Spina M, Bidoli E, Cinelli R, De Paoli P, Carbone A, Tirelli U. Simonelli C, et al. Clin Infect Dis. 2005 Apr 1;40(7):1022-7. doi: 10.1086/428615. Epub 2005 Mar 4. Clin Infect Dis. 2005. PMID: 15824995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters